We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6674:TSEGS Yuasa Corporation Analysis

Data as of 2026-06-22 - not real-time

NT$17.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at TWD 17.4, which sits below the 20‑day, 50‑day and 200‑day simple moving averages of 17.81, 18.11 and 19.95 respectively, signaling a sustained bearish bias. Momentum is neutral‑ish with an RSI of 45.4, while the MACD line remains under the signal line, producing a bearish histogram. Price is hugging the identified support level around 16.65 and is still below the resistance zone near 18.85, making the next move critical. Trading volume has been on a downward trend, and the 30‑day volatility is elevated at roughly 37.6%, indicating price swings could be sharp. A low beta of 0.21 suggests limited correlation with broader market moves, yet the max drawdown of -44.3% underscores historical pain.
Fundamentally, the company reports negative earnings with a trailing EPS of -1.13 and operating margins deep in the red at -56%, while free cash flow is also negative. The balance sheet shows modest cash of about TWD 279 million against relatively low debt, giving a debt‑to‑equity of 1.47. Valuation metrics such as a price‑to‑book of 1.31 appear reasonable against an industry PE average of 38.15, but the lack of earnings and a zero dividend make the stock more of a value play than a growth story. Market sentiment is currently in an “Extreme Greed” phase per the fear‑greed index, which may be overstating optimism despite the weak fundamentals.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and price below all major moving averages
  • Decreasing volume and proximity to support level
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential bottoming near support with low beta exposure
  • Reasonable price‑to‑book relative to assets
  • Continued negative cash flow and earnings

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained negative profitability and margins
  • Elevated historical drawdown and geopolitical exposure
  • Lack of dividend and uncertain growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth-33.90%
Profit Margin-22.76%
ROE-13.66%
ROA-4.88%
Debt/Equity1.47
P/B Ratio1.3
Op. Cash FlowNT$-211846000
Free Cash FlowNT$-210888000
Industry P/E38.1

Technical Analysis

TrendBearish
RSI45.4
SupportNT$16.65
ResistanceNT$18.85
MA 20NT$17.81
MA 50NT$18.11
MA 200NT$19.95
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

GradeFair
TypeValue

Risk Assessment

Beta0.21
Volatility37.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.